Tokio Marine Asset Management Co. Ltd. increased its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 5.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,684 shares of the financial services provider’s stock after buying an additional 492 shares during the period. Tokio Marine Asset Management Co. Ltd.’s holdings in CME Group were worth $2,137,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of CME. Wealth Enhancement Advisory Services LLC lifted its stake in shares of CME Group by 21.2% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock valued at $9,477,000 after purchasing an additional 8,443 shares during the period. Cetera Investment Advisers lifted its stake in CME Group by 429.1% in the first quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock valued at $10,231,000 after buying an additional 38,540 shares during the period. Brookstone Capital Management boosted its holdings in CME Group by 12.2% during the second quarter. Brookstone Capital Management now owns 30,555 shares of the financial services provider’s stock worth $6,156,000 after buying an additional 3,325 shares during the last quarter. Epoch Investment Partners Inc. grew its position in shares of CME Group by 4.7% during the 1st quarter. Epoch Investment Partners Inc. now owns 99,947 shares of the financial services provider’s stock worth $21,518,000 after buying an additional 4,454 shares during the period. Finally, Mather Group LLC. increased its stake in shares of CME Group by 197.2% in the 2nd quarter. Mather Group LLC. now owns 6,066 shares of the financial services provider’s stock valued at $1,306,000 after acquiring an additional 4,025 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several research firms recently weighed in on CME. Citigroup lifted their price objective on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research note on Thursday, October 24th. Oppenheimer lifted their price target on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research report on Thursday, October 24th. Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target for the company. in a report on Tuesday, October 8th. Morgan Stanley raised their price objective on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. Finally, Barclays boosted their target price on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research note on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $224.47.
CME Group Stock Down 2.1 %
CME Group stock opened at $223.42 on Friday. The company has a fifty day simple moving average of $222.44 and a 200 day simple moving average of $210.17. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $230.36. The company has a market cap of $80.45 billion, a P/E ratio of 23.49, a price-to-earnings-growth ratio of 5.69 and a beta of 0.55.
CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the business earned $2.25 earnings per share. CME Group’s quarterly revenue was up 18.4% on a year-over-year basis. Research analysts anticipate that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.
CME Group Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be issued a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.06%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s payout ratio is presently 48.37%.
Insider Activity at CME Group
In other CME Group news, Director Martin J. Gepsman sold 400 shares of the firm’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the sale, the director now directly owns 25,067 shares in the company, valued at $5,587,935.64. This trade represents a 1.57 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of the business’s stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the sale, the insider now directly owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. The trade was a 15.89 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 15,621 shares of company stock valued at $3,441,063. 0.30% of the stock is owned by corporate insiders.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- What is a Bond Market Holiday? How to Invest and Trade
- 3 Stocks Near 52-Week Lows That Could Be Top Buys Right Now
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- How to Use the MarketBeat Dividend Calculator
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.